Publicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (11)

2024

  1. Understanding the nebulisation of antibiotics: the key role of lung microdialysis studies

    Critical Care, Vol. 28, Núm. 1

2023

  1. Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (Intensive Care Medicine, (2023), 49, 6, (615-632), 10.1007/s00134-023-07033-8)

    Intensive Care Medicine

  2. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    Intensive Care Medicine, Vol. 49, Núm. 6, pp. 615-632

  3. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

    European Respiratory Journal, Vol. 61, Núm. 4

  4. Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: A pooled analysis from the Phase 3 clinical trial programme

    Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 11, pp. 2672-2682

2021

  1. Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2399-2414

  2. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  3. Nosocomial Infection

    Critical Care Medicine, Vol. 49, Núm. 2, pp. 169-187

  4. Short-term effects of appropriate empirical antimicrobial treatment with ceftolozane/tazobactam in a swine model of nosocomial pneumonia

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 2

2020

  1. Pulmonary infections complicating ARDS

    Intensive Care Medicine, Vol. 46, Núm. 12, pp. 2168-2183

2018

  1. Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia

    ERJ Open Research, Vol. 4, Núm. 2